Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/17409

TDMS Study 99035-01 Pathology Tables

NTP                                    STATISTICAL ANALYSIS OF NON-NEOPLASTIC LESIONS                          REPORT: PEIRPT10     
LAB: Battelle Columbus                          TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                      DATE: 04/14/04       
EXPERIMENT: 99035 TEST: 01                                                                                     TIME: 10:53:58       
TEST TYPE:  26-39 WEEKS                         CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: N01-ES-65406                              ROUTE: GAVAGE                                                  NTP C#: C99035       
PATHOLOGIST: MISSING                                                                                           CAS: 556-52-5        
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
                                                           FINAL #1 MICE                                                            
                                                                                                                                    
                                                                                                                                    
               REASONS FOR REMOVAL:    ALL                                                                                          
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
               REMOVAL DATE RANGE:     ALL                                                                                          
                                                                                                                                    
               TREATMENT GROUPS:       INCLUDE ALL                                                                                  
                                                                                                                                   
NTP                                    STATISTICAL ANALYSIS OF NON-NEOPLASTIC LESIONS                          REPORT: PEIRPT10     
LAB: Battelle Columbus                          TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                      DATE: 04/14/04       
EXPERIMENT: 99035 TEST: 01                                                                                     TIME: 10:53:58       
TEST TYPE:  26-39 WEEKS                         CAGES FROM 0000 TO LAST CAGE                                                        
CONT: N01-ES-65406                              ROUTE: GAVAGE                                                  NTP C#: C99035       
PATHOLOGIST: MISSING                                                                                           CAS: 556-52-5        
                                                                                                                                    
                                                                                                                                    
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS                                                                               
IN THE ANALYSIS OF        TRANSGENIC MODEL EVALUATION II (GLY                                                                       
===============================================================                                                                     
Male Mice                                                                                                                           
------------                                                                                                                        
Organ                                 Morphology                                                                                    
-----                                 ----------                                                                                    
Brain: Cerebellum                      Gliosis                                                                                      
                                       Neuronopathy                                                                                 
Brain: Cerebrum                        Necrosis Focal                                                                               
Brain: Medulla                         Gliosis                                                                                      
                                       Neuronopathy                                                                                 
Brain: Thalamus                        Gliosis                                                                                      
                                       Neuronopathy                                                                                 
Heart: Myocardium                      Degeneration                                                                                 
                                       Mineralization                                                                               
                                       Necrosis                                                                                     
Liver                                  Inflammation Chronic                                                                         
                                       Necrosis Focal                                                                               
Spleen                                 Atrophy                                                                                      
Stomach, Forestomach                   Ulcer                                                                                        
Stomach, Forestomach: Epithelium       Hyperplasia                                                                                  
Stomach, Glandular                     Mineralization                                                                               
Thymus                                 Atrophy                                                                                      
===============================================================                                                                     
Female Mice                                                                                                                         
------------                                                                                                                        
Organ                                  Morphology                                                                                   
-----                                  ----------                                                                                   
Adrenal Cortex: Subcapsular            Hyperplasia                                                                                  
Brain: Cerebellum                      Neuronopathy                                                                                 
Brain: Medulla                         Gliosis                                                                                      
                                       Neuronopathy                                                                                 
Brain: Thalamus                        Neuronopathy                                                                                 
Kidney: Renal Tubule                   Accumulation, Hyaline Droplet                                                                
Liver                                  Angiectasis Focal                                                                            
                                       Necrosis Focal                                                                               
Lung                                   Inflammation                                                                                 
Lymph Node: Mediastinal                Hyperplasia Lymphoid                                                                         
Ovary                                  Cyst                                                                                         
Spleen                                 Hematopoietic Cell Proliferation                                                             
Stomach, Forestomach: Epithelium       Hyperplasia                                                                                  
Stomach, Glandular                     Mineralization                                                                               
Stomach, Glandular: Muscularis         Mineralization                                                                               
Thymus                                 Atrophy                                                                                      
===============================================================                                                                     
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 1       
Statistical Analysis of Non-neoplastic Lesions in        Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II 
(GLY                                                                                                                                
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Cortex                                                                                                                   | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        0/15 (0%)        0/15 (0%)        1/14 (7%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        1/13.95          0/14.74          0/13.80          1/14.00          0/11.42                          | 
|POLY-3 PERCENT (g) |        7.2%             0.0%             0.0%             7.1%             0.0%                             | 
|TERMINAL (d)       |        1/13 (8%)        0/14 (0%)        0/13 (0%)        1/14 (7%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        280 (T)          ---              ---              280 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.617N         P=0.485N         P=0.500N         P=0.748N         P=0.623N                         | 
|POLY 3             |        P=0.533N         P=0.489N         P=0.502N         P=0.760N         P=0.540N                         | 
|POLY 1.5           |        P=0.522N         P=0.493N         P=0.502N         P=0.755          P=0.522N                         | 
|POLY 6             |        P=0.545N         P=0.485N         P=0.500N         P=0.752N         P=0.562N                         | 
|LOGISTIC REGRESSION|        P=0.617N         (e)              (e)              P=0.748N         (e)                              | 
|COCH-ARM / FISHERS |        P=0.503N         P=0.500N         P=0.500N         P=0.741          P=0.500N                         | 
|ORDER RESTRICTED   |        P=0.271N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Cortex                                                                                                                   | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        2/15 (13%)       0/15 (0%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.88          2/14.62          0/14.15          0/14.62          1/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             13.7%            0.0%             0.0%             8.1%                             | 
|TERMINAL (d)       |        0/13 (0%)        2/14 (14%)       0/12 (0%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              281 (T)          ---              ---              281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.503          P=0.252          (e)              (e)              P=0.427                          | 
|POLY 3             |        P=0.566          P=0.243          (e)              (e)              P=0.478                          | 
|POLY 1.5           |        P=0.576          P=0.243          (e)              (e)              P=0.488                          | 
|POLY 6             |        P=0.556          P=0.242          (e)              (e)              P=0.466                          | 
|LOGISTIC REGRESSION|        (e)              P=0.252          (e)              (e)              P=0.427                          | 
|COCH-ARM / FISHERS |        P=0.583          P=0.241          (e)              (e)              P=0.500                          | 
|ORDER RESTRICTED   |        P=0.277          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 2       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Cortex: Subcapsular                                                                                                      | 
|     Hyperplasia                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        2/15 (13%)       2/15 (13%)       3/14 (21%)       1/15 (7%)                        | 
|POLY-3 RATE (b)    |        1/13.95          2/14.74          2/13.80          3/14.00          1/11.42                          | 
|POLY-3 PERCENT (g) |        7.2%             13.6%            14.5%            21.4%            8.8%                             | 
|TERMINAL (d)       |        1/13 (8%)        2/14 (14%)       2/13 (15%)       3/14 (21%)       1/7 (14%)                        | 
|FIRST INCIDENCE    |        280 (T)          280 (T)          280 (T)          280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.408          P=0.527          P=0.500          P=0.325          P=0.620                          | 
|POLY 3             |        P=0.499          P=0.519          P=0.496          P=0.298          P=0.715                          | 
|POLY 1.5           |        P=0.560          P=0.512          P=0.496          P=0.288          P=0.736                          | 
|POLY 6             |        P=0.423          P=0.527          P=0.499          P=0.311          P=0.686                          | 
|LOGISTIC REGRESSION|        P=0.408          P=0.527          P=0.500          P=0.325          P=0.620                          | 
|COCH-ARM / FISHERS |        P=0.556N         P=0.500          P=0.500          P=0.272          P=0.759N                         | 
|ORDER RESTRICTED   |        P=0.480          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Cortex: Subcapsular                                                                                                      | 
|     Hyperplasia                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        15/15 (100%)     15/15 (100%)     10/15 (67%)      14/15 (93%)      15/15 (100%)                     | 
|POLY-3 RATE (b)    |        15/15.00         15/15.00         10/14.59         14/15.00         15/15.00                         | 
|POLY-3 PERCENT (g) |        100.0%           100.0%           68.6%            93.3%            100.0%                           | 
|TERMINAL (d)       |        13/13 (100%)     14/14 (100%)     9/12 (75%)       13/14 (93%)      9/9 (100%)                       | 
|FIRST INCIDENCE    |        83               239              232              239              133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.017 *        (e)              P=0.097N         P=0.309N         (e)                              | 
|POLY 3             |        P=0.396          (e)              P=0.020N*        P=0.500N         (e)                              | 
|POLY 1.5           |        P=0.384          (e)              P=0.018N*        P=0.500N         (e)                              | 
|POLY 6             |        P=0.414          (e)              P=0.025N*        P=0.500N         (e)                              | 
|LOGISTIC REGRESSION|        P=0.392          (e)              P=0.025N*        (e)              (e)                              | 
|COCH-ARM / FISHERS |        P=0.382          (e)              P=0.021N*        P=0.500N         (e)                              | 
|ORDER RESTRICTED   |        P=0.115N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 3       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebellum                                                                                                                | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          2/12.20                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             16.4%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              210                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.013 *        (e)              (e)              (e)              P=0.192                          | 
|POLY 3             |        P=0.016 *        (e)              (e)              (e)              P=0.200                          | 
|POLY 1.5           |        P=0.017 *        (e)              (e)              (e)              P=0.213                          | 
|POLY 6             |        P=0.016 *        (e)              (e)              (e)              P=0.185                          | 
|LOGISTIC REGRESSION|        P=0.053          (e)              (e)              (e)              P=0.345                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.009 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebellum                                                                                                                | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          1/13.01                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             7.7%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              208                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.129          (e)              (e)              (e)              P=0.485                          | 
|POLY 3             |        P=0.135          (e)              (e)              (e)              P=0.487                          | 
|POLY 1.5           |        P=0.138          (e)              (e)              (e)              P=0.494                          | 
|POLY 6             |        P=0.132          (e)              (e)              (e)              P=0.480                          | 
|LOGISTIC REGRESSION|        P=0.177          (e)              (e)              (e)              P=0.498                          | 
|COCH-ARM / FISHERS |        P=0.143          (e)              (e)              (e)              P=0.500                          | 
|ORDER RESTRICTED   |        P=0.077          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 4       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebellum                                                                                                                | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          3/12.93                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             23.2%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.002 **       (e)              (e)              (e)              P=0.099                          | 
|POLY 3             |        P=0.002 **       (e)              (e)              (e)              P=0.090                          | 
|POLY 1.5           |        P=0.002 **       (e)              (e)              (e)              P=0.097                          | 
|POLY 6             |        P=0.002 **       (e)              (e)              (e)              P=0.082                          | 
|LOGISTIC REGRESSION|        P=0.019 *        (e)              (e)              (e)              P=0.277                          | 
|COCH-ARM / FISHERS |        P=0.003 **       (e)              (e)              (e)              P=0.112                          | 
|ORDER RESTRICTED   |        P=0.002 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebellum                                                                                                                | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          1/14.62          3/13.90                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             6.8%             21.6%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        1/14 (7%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              281 (T)          133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.003 **       (e)              (e)              P=0.515          P=0.102                          | 
|POLY 3             |        P=0.004 **       (e)              (e)              P=0.510          P=0.105                          | 
|POLY 1.5           |        P=0.004 **       (e)              (e)              P=0.510          P=0.108                          | 
|POLY 6             |        P=0.004 **       (e)              (e)              P=0.509          P=0.100                          | 
|LOGISTIC REGRESSION|        P=0.012 *        (e)              (e)              P=0.515          P=0.104                          | 
|COCH-ARM / FISHERS |        P=0.005 **       (e)              (e)              P=0.500          P=0.112                          | 
|ORDER RESTRICTED   |        P=0.008 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 5       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebrum                                                                                                                  | 
|     Necrosis Focal                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          2/12.04                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             16.6%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              210                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.011 *        (e)              (e)              (e)              P=0.180                          | 
|POLY 3             |        P=0.016 *        (e)              (e)              (e)              P=0.197                          | 
|POLY 1.5           |        P=0.017 *        (e)              (e)              (e)              P=0.211                          | 
|POLY 6             |        P=0.016 *        (e)              (e)              (e)              P=0.180                          | 
|LOGISTIC REGRESSION|        P=0.046 *        (e)              (e)              (e)              P=0.306                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.009 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Cerebrum                                                                                                                  | 
|     Necrosis Focal                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 6       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Medulla                                                                                                                   | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          2/12.73                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             15.7%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.021 *        (e)              (e)              (e)              P=0.232                          | 
|POLY 3             |        P=0.017 *        (e)              (e)              (e)              P=0.209                          | 
|POLY 1.5           |        P=0.018 *        (e)              (e)              (e)              P=0.219                          | 
|POLY 6             |        P=0.016 *        (e)              (e)              (e)              P=0.195                          | 
|LOGISTIC REGRESSION|        P=0.062          (e)              (e)              (e)              P=0.476                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.010 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Medulla                                                                                                                   | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          2/13.31                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             15.0%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.015 *        (e)              (e)              (e)              P=0.207                          | 
|POLY 3             |        P=0.018 *        (e)              (e)              (e)              P=0.221                          | 
|POLY 1.5           |        P=0.018 *        (e)              (e)              (e)              P=0.229                          | 
|POLY 6             |        P=0.017 *        (e)              (e)              (e)              P=0.210                          | 
|LOGISTIC REGRESSION|        P=0.037 *        (e)              (e)              (e)              P=0.225                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.012 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 7       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Medulla                                                                                                                   | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          3/12.93                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             23.2%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.002 **       (e)              (e)              (e)              P=0.099                          | 
|POLY 3             |        P=0.002 **       (e)              (e)              (e)              P=0.090                          | 
|POLY 1.5           |        P=0.002 **       (e)              (e)              (e)              P=0.097                          | 
|POLY 6             |        P=0.002 **       (e)              (e)              (e)              P=0.082                          | 
|LOGISTIC REGRESSION|        P=0.019 *        (e)              (e)              (e)              P=0.277                          | 
|COCH-ARM / FISHERS |        P=0.003 **       (e)              (e)              (e)              P=0.112                          | 
|ORDER RESTRICTED   |        P=0.002 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Medulla                                                                                                                   | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          3/14.02                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             21.4%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.002 **       (e)              (e)              (e)              P=0.106                          | 
|POLY 3             |        P=0.002 **       (e)              (e)              (e)              P=0.106                          | 
|POLY 1.5           |        P=0.002 **       (e)              (e)              (e)              P=0.110                          | 
|POLY 6             |        P=0.002 **       (e)              (e)              (e)              P=0.101                          | 
|LOGISTIC REGRESSION|        P=0.007 **       (e)              (e)              (e)              P=0.099                          | 
|COCH-ARM / FISHERS |        P=0.003 **       (e)              (e)              (e)              P=0.112                          | 
|ORDER RESTRICTED   |        P=0.003 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 8       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Thalamus                                                                                                                  | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          2/12.59                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             15.9%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              208                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.020 *        (e)              (e)              (e)              P=0.232                          | 
|POLY 3             |        P=0.017 *        (e)              (e)              (e)              P=0.207                          | 
|POLY 1.5           |        P=0.018 *        (e)              (e)              (e)              P=0.217                          | 
|POLY 6             |        P=0.016 *        (e)              (e)              (e)              P=0.194                          | 
|LOGISTIC REGRESSION|        P=0.065          (e)              (e)              (e)              P=0.475                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.010 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Thalamus                                                                                                                  | 
|     Gliosis                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          1/13.12                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             7.6%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.138          (e)              (e)              (e)              P=0.500                          | 
|POLY 3             |        P=0.136          (e)              (e)              (e)              P=0.489                          | 
|POLY 1.5           |        P=0.139          (e)              (e)              (e)              P=0.495                          | 
|POLY 6             |        P=0.133          (e)              (e)              (e)              P=0.481                          | 
|LOGISTIC REGRESSION|        P=0.170          (e)              (e)              (e)              P=0.481                          | 
|COCH-ARM / FISHERS |        P=0.143          (e)              (e)              (e)              P=0.500                          | 
|ORDER RESTRICTED   |        P=0.079          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 9       
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Thalamus                                                                                                                  | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        5/15 (33%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          5/13.56                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             36.9%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              (e)              P=0.022 *                        | 
|POLY 3             |        P<0.001 **       (e)              (e)              (e)              P=0.014 *                        | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              (e)              P=0.015 *                        | 
|POLY 6             |        P<0.001 **       (e)              (e)              (e)              P=0.012 *                        | 
|LOGISTIC REGRESSION|        P<0.001 **       (e)              (e)              (e)              P=0.077                          | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              (e)              P=0.021 *                        | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Brain: Thalamus                                                                                                                  | 
|     Neuronopathy                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          3/14.61                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             20.5%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.003 **       (e)              (e)              (e)              P=0.124                          | 
|POLY 3             |        P=0.002 **       (e)              (e)              (e)              P=0.115                          | 
|POLY 1.5           |        P=0.002 **       (e)              (e)              (e)              P=0.115                          | 
|POLY 6             |        P=0.002 **       (e)              (e)              (e)              P=0.113                          | 
|LOGISTIC REGRESSION|        P=0.003 **       (e)              (e)              (e)              P=0.074                          | 
|COCH-ARM / FISHERS |        P=0.003 **       (e)              (e)              (e)              P=0.112                          | 
|ORDER RESTRICTED   |        P=0.003 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 10      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Degeneration                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       0/15 (0%)        0/15 (0%)        2/15 (13%)       0/15 (0%)                        | 
|POLY-3 RATE (b)    |        2/15.00          0/14.74          0/13.80          2/14.37          0/11.42                          | 
|POLY-3 PERCENT (g) |        13.3%            0.0%             0.0%             13.9%            0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        2/14 (14%)       0/7 (0%)                         | 
|FIRST INCIDENCE    |        196              ---              ---              280 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.453N         P=0.232N         P=0.247N         P=0.680N         P=0.285N                         | 
|POLY 3             |        P=0.420N         P=0.236N         P=0.251N         P=0.683          P=0.298N                         | 
|POLY 1.5           |        P=0.393N         P=0.234N         P=0.244N         P=0.689          P=0.268N                         | 
|POLY 6             |        P=0.452N         P=0.239N         P=0.257N         P=0.677          P=0.339N                         | 
|LOGISTIC REGRESSION|        P=0.243N         (e)              P=0.121N         P=0.667          P=0.049N*                        | 
|COCH-ARM / FISHERS |        P=0.358N         P=0.241N         P=0.241N         P=0.701N         P=0.241N                         | 
|ORDER RESTRICTED   |        P=0.129N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Degeneration                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 11      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        2/15 (13%)       1/15 (7%)        5/15 (33%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          2/14.66          1/14.37          5/13.21                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             13.6%            7.0%             37.9%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        1/13 (8%)        1/14 (7%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              146              280 (T)          208                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              P=0.240          P=0.515          P=0.019 *                        | 
|POLY 3             |        P<0.001 **       (e)              P=0.243          P=0.506          P=0.012 *                        | 
|POLY 1.5           |        P<0.001 **       (e)              P=0.238          P=0.503          P=0.014 *                        | 
|POLY 6             |        P<0.001 **       (e)              P=0.247          P=0.509          P=0.011 *                        | 
|LOGISTIC REGRESSION|        P=0.015 *        (e)              P=0.292          P=0.515          P=0.054                          | 
|COCH-ARM / FISHERS |        P=0.002 **       (e)              P=0.241          P=0.500          P=0.021 *                        | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        1/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        7.2%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        1/13 (8%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        281 (T)          ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.397N         P=0.485N         P=0.516N         P=0.485N         P=0.573N                         | 
|POLY 3             |        P=0.342N         P=0.490N         P=0.496N         P=0.490N         P=0.522N                         | 
|POLY 1.5           |        P=0.353N         P=0.490N         P=0.494N         P=0.490N         P=0.512N                         | 
|POLY 6             |        P=0.329N         P=0.491N         P=0.501N         P=0.491N         P=0.534N                         | 
|LOGISTIC REGRESSION|        P=0.397N         (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        P=0.361N         P=0.500N         P=0.500N         P=0.500N         P=0.500N                         | 
|ORDER RESTRICTED   |        P=0.107N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 12      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Necrosis                                                                                                                    | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          2/11.66                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             17.2%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              260                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.007 **       (e)              (e)              (e)              P=0.152                          | 
|POLY 3             |        P=0.016 *        (e)              (e)              (e)              P=0.190                          | 
|POLY 1.5           |        P=0.017 *        (e)              (e)              (e)              P=0.207                          | 
|POLY 6             |        P=0.015 *        (e)              (e)              (e)              P=0.171                          | 
|LOGISTIC REGRESSION|        P=0.018 *        (e)              (e)              (e)              P=0.189                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.008 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Heart: Myocardium                                                                                                                | 
|     Necrosis                                                                                                                    | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 13      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Kidney                                                                                                                           | 
|     Nephropathy                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        4/15 (27%)       5/15 (33%)       5/15 (33%)       4/15 (27%)       4/15 (27%)                       | 
|POLY-3 RATE (b)    |        4/13.95          5/15.00          5/13.80          4/14.37          4/11.42                          | 
|POLY-3 PERCENT (g) |        28.7%            33.3%            36.2%            27.8%            35.0%                            | 
|TERMINAL (d)       |        4/13 (31%)       4/14 (29%)       5/13 (39%)       4/14 (29%)       4/7 (57%)                        | 
|FIRST INCIDENCE    |        280 (T)          253              280 (T)          280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.261          P=0.556          P=0.500          P=0.615N         P=0.257                          | 
|POLY 3             |        P=0.512          P=0.551          P=0.493          P=0.639N         P=0.534                          | 
|POLY 1.5           |        P=0.549N         P=0.530          P=0.491          P=0.647N         P=0.590                          | 
|POLY 6             |        P=0.432          P=0.574          P=0.499          P=0.629N         P=0.455                          | 
|LOGISTIC REGRESSION|        P=0.380          P=0.534          P=0.500          P=0.615N         P=0.257                          | 
|COCH-ARM / FISHERS |        P=0.464N         P=0.500          P=0.500          P=0.659N         P=0.659N                         | 
|ORDER RESTRICTED   |        P=0.638          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Kidney                                                                                                                           | 
|     Nephropathy                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        12/15 (80%)      12/15 (80%)      10/15 (67%)      14/15 (93%)      9/15 (60%)                       | 
|POLY-3 RATE (b)    |        12/14.86         12/15.00         10/14.15         14/15.00         9/13.49                          | 
|POLY-3 PERCENT (g) |        80.8%            80.0%            70.7%            93.3%            66.7%                            | 
|TERMINAL (d)       |        11/13 (85%)      11/14 (79%)      10/12 (83%)      13/14 (93%)      6/9 (67%)                        | 
|FIRST INCIDENCE    |        83               239              281 (T)          239              186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.347          P=0.524N         P=0.470N         P=0.486          P=0.605                          | 
|POLY 3             |        P=0.348N         P=0.655N         P=0.420N         P=0.317          P=0.336N                         | 
|POLY 1.5           |        P=0.298N         P=0.662N         P=0.384N         P=0.308          P=0.294N                         | 
|POLY 6             |        P=0.378N         P=0.640N         P=0.472N         P=0.334          P=0.364N                         | 
|LOGISTIC REGRESSION|        P=0.245N         P=0.654          P=0.326N         P=0.280          P=0.226N                         | 
|COCH-ARM / FISHERS |        P=0.195N         P=0.674N         P=0.341N         P=0.299          P=0.213N                         | 
|ORDER RESTRICTED   |        P=0.292N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 14      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Kidney: Renal Tubule                                                                                                             | 
|     Accumulation, Hyaline Droplet                                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        1/15 (7%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          1/14.14          0/14.37          1/11.62                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             7.1%             0.0%             8.6%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              244              ---              260                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.228          (e)              P=0.515          (e)              P=0.427                          | 
|POLY 3             |        P=0.263          (e)              P=0.503          (e)              P=0.464                          | 
|POLY 1.5           |        P=0.281          (e)              P=0.500          (e)              P=0.479                          | 
|POLY 6             |        P=0.244          (e)              P=0.508          (e)              P=0.444                          | 
|LOGISTIC REGRESSION|        P=0.382          (e)              P=0.538          (e)              P=0.506                          | 
|COCH-ARM / FISHERS |        P=0.306          (e)              P=0.500          (e)              P=0.500                          | 
|ORDER RESTRICTED   |        P=0.185          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Kidney: Renal Tubule                                                                                                             | 
|     Accumulation, Hyaline Droplet                                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        2/15 (13%)       1/15 (7%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          2/14.59          1/14.62          3/13.48                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             13.7%            6.8%             22.3%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        1/12 (8%)        1/14 (7%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              232              281 (T)          186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.022 *        (e)              P=0.238          P=0.515          P=0.100                          | 
|POLY 3             |        P=0.030 *        (e)              P=0.243          P=0.510          P=0.099                          | 
|POLY 1.5           |        P=0.032 *        (e)              P=0.242          P=0.510          P=0.103                          | 
|POLY 6             |        P=0.029 *        (e)              P=0.241          P=0.509          P=0.096                          | 
|LOGISTIC REGRESSION|        P=0.054          (e)              P=0.201          P=0.515          P=0.117                          | 
|COCH-ARM / FISHERS |        P=0.035 *        (e)              P=0.241          P=0.500          P=0.112                          | 
|ORDER RESTRICTED   |        P=0.026 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 15      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Angiectasis Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          0/14.37          1/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             8.8%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        1/7 (14%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.074          (e)              (e)              (e)              P=0.377                          | 
|POLY 3             |        P=0.123          (e)              (e)              (e)              P=0.460                          | 
|POLY 1.5           |        P=0.132          (e)              (e)              (e)              P=0.478                          | 
|POLY 6             |        P=0.114          (e)              (e)              (e)              P=0.437                          | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              P=0.377                          | 
|COCH-ARM / FISHERS |        P=0.143          (e)              (e)              (e)              P=0.500                          | 
|ORDER RESTRICTED   |        P=0.061          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Angiectasis Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          1/14.62          2/12.44                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             6.8%             16.1%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        1/14 (7%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              281 (T)          278                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.015 *        (e)              (e)              P=0.515          P=0.183                          | 
|POLY 3             |        P=0.023 *        (e)              (e)              P=0.510          P=0.205                          | 
|POLY 1.5           |        P=0.025 *        (e)              (e)              P=0.510          P=0.217                          | 
|POLY 6             |        P=0.021 *        (e)              (e)              P=0.509          P=0.194                          | 
|LOGISTIC REGRESSION|        P=0.018 *        (e)              (e)              P=0.515          P=0.188                          | 
|COCH-ARM / FISHERS |        P=0.030 *        (e)              (e)              P=0.500          P=0.241                          | 
|ORDER RESTRICTED   |        P=0.033 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 16      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Hematopoietic Cell Proliferation                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        1/15 (7%)        0/15 (0%)        2/15 (13%)       1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.95          1/14.74          0/13.80          2/14.37          1/11.95                          | 
|POLY-3 PERCENT (g) |        0.0%             6.8%             0.0%             13.9%            8.4%                             | 
|TERMINAL (d)       |        0/13 (0%)        1/14 (7%)        0/13 (0%)        2/14 (14%)       0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              280 (T)          ---              280 (T)          217                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.171          P=0.515          (e)              P=0.252          P=0.469                          | 
|POLY 3             |        P=0.224          P=0.511          (e)              P=0.238          P=0.469                          | 
|POLY 1.5           |        P=0.254          P=0.507          (e)              P=0.235          P=0.482                          | 
|POLY 6             |        P=0.190          P=0.515          (e)              P=0.242          P=0.452                          | 
|LOGISTIC REGRESSION|        P=0.322          P=0.515          (e)              P=0.252          P=0.688                          | 
|COCH-ARM / FISHERS |        P=0.293          P=0.500          (e)              P=0.241          P=0.500                          | 
|ORDER RESTRICTED   |        P=0.198          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Hematopoietic Cell Proliferation                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       3/15 (20%)       1/15 (7%)        1/15 (7%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        2/13.88          3/14.62          1/14.15          1/14.62          2/12.44                          | 
|POLY-3 PERCENT (g) |        14.4%            20.5%            7.1%             6.8%             16.1%                            | 
|TERMINAL (d)       |        2/13 (15%)       3/14 (21%)       1/12 (8%)        1/14 (7%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        281 (T)          281 (T)          281 (T)          281 (T)          278                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.567          P=0.536          P=0.529N         P=0.473N         P=0.577                          | 
|POLY 3             |        P=0.521N         P=0.524          P=0.493N         P=0.482N         P=0.659                          | 
|POLY 1.5           |        P=0.512N         P=0.523          P=0.489N         P=0.483N         P=0.679                          | 
|POLY 6             |        P=0.528N         P=0.522          P=0.502N         P=0.484N         P=0.638                          | 
|LOGISTIC REGRESSION|        P=0.596N         P=0.536          P=0.529N         P=0.473N         P=0.626                          | 
|COCH-ARM / FISHERS |        P=0.500N         P=0.500          P=0.500N         P=0.500N         P=0.701N                         | 
|ORDER RESTRICTED   |        P=0.494N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 17      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Infiltration Cellular Lymphoid                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        2/15 (13%)       0/15 (0%)        2/15 (13%)       1/15 (7%)                        | 
|POLY-3 RATE (b)    |        1/14.34          2/14.74          0/13.80          2/14.37          1/11.42                          | 
|POLY-3 PERCENT (g) |        7.0%             13.6%            0.0%             13.9%            8.8%                             | 
|TERMINAL (d)       |        0/13 (0%)        2/14 (14%)       0/13 (0%)        2/14 (14%)       1/7 (14%)                        | 
|FIRST INCIDENCE    |        237              280 (T)          ---              280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.441          P=0.525          P=0.500N         P=0.517          P=0.651                          | 
|POLY 3             |        P=0.514          P=0.510          P=0.508N         P=0.501          P=0.708                          | 
|POLY 1.5           |        P=0.560          P=0.507          P=0.505N         P=0.501          P=0.732                          | 
|POLY 6             |        P=0.456          P=0.511          P=0.510N         P=0.500          P=0.674                          | 
|LOGISTIC REGRESSION|        P=0.580          P=0.414          P=0.448N         P=0.483          P=0.768N                         | 
|COCH-ARM / FISHERS |        P=0.618          P=0.500          P=0.500N         P=0.500          P=0.759N                         | 
|ORDER RESTRICTED   |        P=0.596          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Infiltration Cellular Lymphoid                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        3/15 (20%)       1/15 (7%)        1/15 (7%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.88          3/14.62          1/14.15          1/14.62          1/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             20.5%            7.1%             6.8%             8.1%                             | 
|TERMINAL (d)       |        0/13 (0%)        3/14 (21%)       1/12 (8%)        1/14 (7%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        ---              281 (T)          281 (T)          281 (T)          281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.569          P=0.128          P=0.484          P=0.515          P=0.427                          | 
|POLY 3             |        P=0.581N         P=0.115          P=0.504          P=0.510          P=0.478                          | 
|POLY 1.5           |        P=0.569N         P=0.115          P=0.506          P=0.510          P=0.488                          | 
|POLY 6             |        P=0.593N         P=0.114          P=0.499          P=0.509          P=0.466                          | 
|LOGISTIC REGRESSION|        (e)              P=0.128          P=0.484          P=0.515          P=0.427                          | 
|COCH-ARM / FISHERS |        P=0.560N         P=0.112          P=0.500          P=0.500          P=0.500                          | 
|ORDER RESTRICTED   |        P=0.295          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 18      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Inflammation Chronic                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        6/15 (40%)       9/15 (60%)       8/15 (53%)       9/15 (60%)       2/15 (13%)                       | 
|POLY-3 RATE (b)    |        6/13.95          9/14.74          8/13.80          9/15.00          2/11.95                          | 
|POLY-3 PERCENT (g) |        43.0%            61.1%            58.0%            60.0%            16.7%                            | 
|TERMINAL (d)       |        6/13 (46%)       9/14 (64%)       8/13 (62%)       8/14 (57%)       1/7 (14%)                        | 
|FIRST INCIDENCE    |        280 (T)          280 (T)          280 (T)          201              217                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.263N         P=0.291          P=0.350          P=0.304          P=0.361N                         | 
|POLY 3             |        P=0.070N         P=0.278          P=0.343          P=0.296          P=0.152N                         | 
|POLY 1.5           |        P=0.046N*        P=0.261          P=0.344          P=0.270          P=0.129N                         | 
|POLY 6             |        P=0.111N         P=0.295          P=0.350          P=0.329          P=0.188N                         | 
|LOGISTIC REGRESSION|        P=0.084N         P=0.291          P=0.350          P=0.241          P=0.185N                         | 
|COCH-ARM / FISHERS |        P=0.030N*        P=0.233          P=0.358          P=0.233          P=0.107N                         | 
|ORDER RESTRICTED   |        P=0.036N*        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Inflammation Chronic                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        11/15 (73%)      10/15 (67%)      8/15 (53%)       8/15 (53%)       7/15 (47%)                       | 
|POLY-3 RATE (b)    |        11/13.88         10/15.00         8/14.15          8/14.62          7/12.44                          | 
|POLY-3 PERCENT (g) |        79.2%            66.7%            56.5%            54.7%            56.3%                            | 
|TERMINAL (d)       |        11/13 (85%)      9/14 (64%)       8/12 (67%)       8/14 (57%)       6/9 (67%)                        | 
|FIRST INCIDENCE    |        281 (T)          239              281 (T)          281 (T)          278                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.418N         P=0.379N         P=0.285N         P=0.132N         P=0.531N                         | 
|POLY 3             |        P=0.167N         P=0.370N         P=0.184N         P=0.158N         P=0.191N                         | 
|POLY 1.5           |        P=0.132N         P=0.394N         P=0.179N         P=0.165N         P=0.149N                         | 
|POLY 6             |        P=0.207N         P=0.351N         P=0.206N         P=0.160N         P=0.248N                         | 
|LOGISTIC REGRESSION|        P=0.232N         P=0.410N         P=0.285N         P=0.132N         P=0.307N                         | 
|COCH-ARM / FISHERS |        P=0.092N         P=0.500N         P=0.225N         P=0.225N         P=0.132N                         | 
|ORDER RESTRICTED   |        P=0.184N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 19      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Necrosis Focal                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        2/15 (13%)       2/15 (13%)       0/15 (0%)        5/15 (33%)                       | 
|POLY-3 RATE (b)    |        1/14.61          2/15.00          2/15.00          0/14.37          5/13.56                          | 
|POLY-3 PERCENT (g) |        6.9%             13.3%            13.3%            0.0%             36.9%                            | 
|TERMINAL (d)       |        0/13 (0%)        1/14 (7%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        196              253              146              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.028 *        P=0.525          P=0.501          P=0.500N         P=0.075                          | 
|POLY 3             |        P=0.035 *        P=0.509          P=0.509          P=0.503N         P=0.062                          | 
|POLY 1.5           |        P=0.038 *        P=0.505          P=0.505          P=0.502N         P=0.069                          | 
|POLY 6             |        P=0.033 *        P=0.515          P=0.515          P=0.503N         P=0.054                          | 
|LOGISTIC REGRESSION|        P=0.452          P=0.170          P=0.381          (e)              P=0.349                          | 
|COCH-ARM / FISHERS |        P=0.046 *        P=0.500          P=0.500          P=0.500N         P=0.084                          | 
|ORDER RESTRICTED   |        P=0.013 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Necrosis Focal                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        5/15 (33%)       2/15 (13%)       2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          5/14.98          2/14.62          2/13.46                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             33.4%            13.7%            14.9%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        3/12 (25%)       2/14 (14%)       0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              232              281 (T)          186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.182          (e)              P=0.030 *        P=0.252          P=0.223                          | 
|POLY 3             |        P=0.231          (e)              P=0.022 *        P=0.243          P=0.223                          | 
|POLY 1.5           |        P=0.243          (e)              P=0.021 *        P=0.243          P=0.228                          | 
|POLY 6             |        P=0.223          (e)              P=0.023 *        P=0.242          P=0.219                          | 
|LOGISTIC REGRESSION|        P=0.324          (e)              P=0.019 *        P=0.252          P=0.231                          | 
|COCH-ARM / FISHERS |        P=0.265          (e)              P=0.021 *        P=0.241          P=0.241                          | 
|ORDER RESTRICTED   |        P=0.070          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 20      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung                                                                                                                             | 
|     Inflammation                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        3/15 (20%)       7/15 (47%)       5/15 (33%)       4/15 (27%)       2/15 (13%)                       | 
|POLY-3 RATE (b)    |        3/13.95          7/14.74          5/13.80          4/14.37          2/11.42                          | 
|POLY-3 PERCENT (g) |        21.5%            47.5%            36.2%            27.8%            17.5%                            | 
|TERMINAL (d)       |        3/13 (23%)       7/14 (50%)       5/13 (39%)       4/14 (29%)       2/7 (29%)                        | 
|FIRST INCIDENCE    |        280 (T)          280 (T)          280 (T)          280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.442N         P=0.152          P=0.338          P=0.545          P=0.604                          | 
|POLY 3             |        P=0.230N         P=0.141          P=0.334          P=0.518          P=0.596N                         | 
|POLY 1.5           |        P=0.187N         P=0.133          P=0.334          P=0.510          P=0.554N                         | 
|POLY 6             |        P=0.287N         P=0.149          P=0.338          P=0.528          P=0.650N                         | 
|LOGISTIC REGRESSION|        P=0.442N         P=0.152          P=0.338          P=0.545          P=0.604                          | 
|COCH-ARM / FISHERS |        P=0.138N         P=0.123          P=0.341          P=0.500          P=0.500N                         | 
|ORDER RESTRICTED   |        P=0.307N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung                                                                                                                             | 
|     Inflammation                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        8/15 (53%)       8/15 (53%)       7/15 (47%)       5/15 (33%)       3/15 (20%)                       | 
|POLY-3 RATE (b)    |        8/13.88          8/15.00          7/14.15          5/14.62          3/12.44                          | 
|POLY-3 PERCENT (g) |        57.6%            53.3%            49.5%            34.2%            24.1%                            | 
|TERMINAL (d)       |        8/13 (62%)       7/14 (50%)       7/12 (58%)       5/14 (36%)       2/9 (22%)                        | 
|FIRST INCIDENCE    |        281 (T)          239              281 (T)          281 (T)          278                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.081N         P=0.558N         P=0.595N         P=0.174N         P=0.206N                         | 
|POLY 3             |        P=0.033N*        P=0.555N         P=0.479N         P=0.191N         P=0.083N                         | 
|POLY 1.5           |        P=0.026N*        P=0.571N         P=0.467N         P=0.194N         P=0.068N                         | 
|POLY 6             |        P=0.042N*        P=0.543N         P=0.508N         P=0.193N         P=0.102N                         | 
|LOGISTIC REGRESSION|        P=0.040N*        P=0.592N         P=0.595N         P=0.174N         P=0.125N                         | 
|COCH-ARM / FISHERS |        P=0.019N*        P=0.642N         P=0.500N         P=0.231N         P=0.064N                         | 
|ORDER RESTRICTED   |        P=0.070N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 21      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung: Alveolar Epithelium                                                                                                        | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        2/15 (13%)       0/15 (0%)        2/15 (13%)       2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          2/14.74          0/13.80          2/14.37          2/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             13.6%            0.0%             13.9%            17.5%                            | 
|TERMINAL (d)       |        0/13 (0%)        2/14 (14%)       0/13 (0%)        2/14 (14%)       2/7 (29%)                        | 
|FIRST INCIDENCE    |        ---              280 (T)          ---              280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.056          P=0.252          (e)              P=0.252          P=0.112                          | 
|POLY 3             |        P=0.128          P=0.244          (e)              P=0.238          P=0.186                          | 
|POLY 1.5           |        P=0.150          P=0.239          (e)              P=0.235          P=0.205                          | 
|POLY 6             |        P=0.103          P=0.249          (e)              P=0.242          P=0.163                          | 
|LOGISTIC REGRESSION|        (e)              P=0.252          (e)              P=0.252          P=0.112                          | 
|COCH-ARM / FISHERS |        P=0.183          P=0.241          (e)              P=0.241          P=0.241                          | 
|ORDER RESTRICTED   |        P=0.110          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung: Alveolar Epithelium                                                                                                        | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        2/15 (13%)       1/15 (7%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        1/13.88          2/14.62          1/14.15          0/14.62          1/12.41                          | 
|POLY-3 PERCENT (g) |        7.2%             13.7%            7.1%             0.0%             8.1%                             | 
|TERMINAL (d)       |        1/13 (8%)        2/14 (14%)       1/12 (8%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        281 (T)          281 (T)          281 (T)          ---              281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.544N         P=0.527          P=0.747          P=0.485N         P=0.680                          | 
|POLY 3             |        P=0.437N         P=0.518          P=0.757N         P=0.490N         P=0.736                          | 
|POLY 1.5           |        P=0.435N         P=0.517          P=0.754N         P=0.490N         P=0.748                          | 
|POLY 6             |        P=0.438N         P=0.516          P=0.760          P=0.491N         P=0.722                          | 
|LOGISTIC REGRESSION|        P=0.544N         P=0.527          P=0.747          (e)              P=0.680                          | 
|COCH-ARM / FISHERS |        P=0.435N         P=0.500          P=0.759N         P=0.500N         P=0.759N                         | 
|ORDER RESTRICTED   |        P=0.452N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 22      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node, Mandibular                                                                                                           | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        2/15 (13%)       0/15 (0%)        1/15 (7%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.95          2/14.74          0/13.80          1/14.37          0/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             13.6%            0.0%             7.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        2/14 (14%)       0/13 (0%)        1/14 (7%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              280 (T)          ---              280 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.551N         P=0.252          (e)              P=0.515          (e)                              | 
|POLY 3             |        P=0.450N         P=0.244          (e)              P=0.506          (e)                              | 
|POLY 1.5           |        P=0.436N         P=0.239          (e)              P=0.503          (e)                              | 
|POLY 6             |        P=0.467N         P=0.249          (e)              P=0.509          (e)                              | 
|LOGISTIC REGRESSION|        (e)              P=0.252          (e)              P=0.515          (e)                              | 
|COCH-ARM / FISHERS |        P=0.417N         P=0.241          (e)              P=0.500          (e)                              | 
|ORDER RESTRICTED   |        P=0.360N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node, Mandibular                                                                                                           | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        1/13.88          0/14.62          0/14.15          0/14.62          1/12.41                          | 
|POLY-3 PERCENT (g) |        7.2%             0.0%             0.0%             0.0%             8.1%                             | 
|TERMINAL (d)       |        1/13 (8%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        281 (T)          ---              ---              ---              281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.430          P=0.485N         P=0.516N         P=0.485N         P=0.680                          | 
|POLY 3             |        P=0.478          P=0.490N         P=0.496N         P=0.490N         P=0.736                          | 
|POLY 1.5           |        P=0.484          P=0.490N         P=0.494N         P=0.490N         P=0.748                          | 
|POLY 6             |        P=0.474          P=0.491N         P=0.501N         P=0.491N         P=0.722                          | 
|LOGISTIC REGRESSION|        P=0.430          (e)              (e)              (e)              P=0.680                          | 
|COCH-ARM / FISHERS |        P=0.500          P=0.500N         P=0.500N         P=0.500N         P=0.759N                         | 
|ORDER RESTRICTED   |        P=0.305          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 23      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node, Mesenteric                                                                                                           | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        2/15 (13%)       0/15 (0%)        1/14 (7%)        1/15 (7%)                        | 
|POLY-3 RATE (b)    |        0/13.95          2/14.74          0/13.80          1/14.00          1/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             13.6%            0.0%             7.1%             8.8%                             | 
|TERMINAL (d)       |        0/13 (0%)        2/14 (14%)       0/13 (0%)        1/14 (7%)        1/7 (14%)                        | 
|FIRST INCIDENCE    |        ---              280 (T)          ---              280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.334          P=0.252          (e)              P=0.515          P=0.377                          | 
|POLY 3             |        P=0.424          P=0.244          (e)              P=0.501          P=0.460                          | 
|POLY 1.5           |        P=0.455          P=0.239          (e)              P=0.495          P=0.478                          | 
|POLY 6             |        P=0.385          P=0.249          (e)              P=0.507          P=0.437                          | 
|LOGISTIC REGRESSION|        (e)              P=0.252          (e)              P=0.515          P=0.377                          | 
|COCH-ARM / FISHERS |        P=0.496          P=0.241          (e)              P=0.483          P=0.500                          | 
|ORDER RESTRICTED   |        P=0.326          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node, Mesenteric                                                                                                           | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          1/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             6.8%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        1/14 (7%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              281 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.603          (e)              (e)              P=0.515          (e)                              | 
|POLY 3             |        P=0.560          (e)              (e)              P=0.510          (e)                              | 
|POLY 1.5           |        P=0.591          (e)              (e)              P=0.510          (e)                              | 
|POLY 6             |        P=0.529          (e)              (e)              P=0.509          (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              P=0.515          (e)                              | 
|COCH-ARM / FISHERS |        P=0.639          (e)              (e)              P=0.500          (e)                              | 
|ORDER RESTRICTED   |        P=0.388          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 24      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node: Mediastinal                                                                                                          | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/14 (0%)        1/14 (7%)        0/15 (0%)        0/13 (0%)        0/13 (0%)                        | 
|POLY-3 RATE (b)    |        0/12.95          1/13.74          0/13.80          0/12.37          0/9.42                           | 
|POLY-3 PERCENT (g) |        0.0%             7.3%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/12 (0%)        1/13 (8%)        0/13 (0%)        0/12 (0%)        0/5 (0%)                         | 
|FIRST INCIDENCE    |        ---              280 (T)          ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.620N         P=0.516          (e)              (e)              (e)                              | 
|POLY 3             |        P=0.469N         P=0.512          (e)              (e)              (e)                              | 
|POLY 1.5           |        P=0.491N         P=0.507          (e)              (e)              (e)                              | 
|POLY 6             |        P=0.435N         P=0.516          (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              P=0.516          (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        P=0.515N         P=0.500          (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        P=0.455N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lymph Node: Mediastinal                                                                                                          | 
|     Hyperplasia Lymphoid                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/13 (15%)       1/15 (7%)        0/15 (0%)        0/13 (0%)        0/14 (0%)                        | 
|POLY-3 RATE (b)    |        2/11.88          1/14.62          0/14.15          0/12.62          0/11.41                          | 
|POLY-3 PERCENT (g) |        16.8%            6.8%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        2/11 (18%)       1/14 (7%)        0/12 (0%)        0/12 (0%)        0/8 (0%)                         | 
|FIRST INCIDENCE    |        281 (T)          281 (T)          ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.130N         P=0.413N         P=0.216N         P=0.216N         P=0.307N                         | 
|POLY 3             |        P=0.101N         P=0.426N         P=0.190N         P=0.216N         P=0.238N                         | 
|POLY 1.5           |        P=0.104N         P=0.428N         P=0.189N         P=0.217N         P=0.225N                         | 
|POLY 6             |        P=0.098N         P=0.428N         P=0.195N         P=0.217N         P=0.253N                         | 
|LOGISTIC REGRESSION|        P=0.130N         P=0.413N         (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        P=0.106N         P=0.444N         P=0.206N         P=0.240N         P=0.222N                         | 
|ORDER RESTRICTED   |        P=0.047N*        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 25      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Ovary                                                                                                                            | 
|     Cyst                                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |                                                                                                             | 
|POLY-3 RATE (b)    |                                                                                                             | 
|POLY-3 PERCENT (g) |                                                                                                             | 
|TERMINAL (d)       |                                                                                                             | 
|FIRST INCIDENCE    |                                                                                                             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |                                                                                                             | 
|POLY 3             |                                                                                                             | 
|POLY 1.5           |                                                                                                             | 
|POLY 6             |                                                                                                             | 
|LOGISTIC REGRESSION|                                                                                                             | 
|COCH-ARM / FISHERS |                                                                                                             | 
|ORDER RESTRICTED   |                                                                                                             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Ovary                                                                                                                            | 
|     Cyst                                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        4/15 (27%)       0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        4/13.88          0/14.62          0/14.15          0/14.62          2/13.12                          | 
|POLY-3 PERCENT (g) |        28.8%            0.0%             0.0%             0.0%             15.2%                            | 
|TERMINAL (d)       |        4/13 (31%)       0/14 (0%)        0/12 (0%)        0/14 (0%)        1/9 (11%)                        | 
|FIRST INCIDENCE    |        281 (T)          ---              ---              ---              186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.603N         P=0.047N*        P=0.064N         P=0.047N*        P=0.484N                         | 
|POLY 3             |        P=0.504N         P=0.038N*        P=0.042N*        P=0.038N*        P=0.353N                         | 
|POLY 1.5           |        P=0.508N         P=0.039N*        P=0.041N*        P=0.039N*        P=0.337N                         | 
|POLY 6             |        P=0.496N         P=0.039N*        P=0.044N*        P=0.039N*        P=0.372N                         | 
|LOGISTIC REGRESSION|        P=0.477N         (e)              (e)              (e)              P=0.330N                         | 
|COCH-ARM / FISHERS |        P=0.500N         P=0.050N         P=0.050N         P=0.050N         P=0.326N                         | 
|ORDER RESTRICTED   |        P=0.011N*        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 26      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pituitary Gland: Pars Distalis                                                                                                   | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/14 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/12.80          0/14.37          0/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pituitary Gland: Pars Distalis                                                                                                   | 
|     Hyperplasia Focal                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/15 (7%)        1/15 (7%)        2/15 (13%)       1/15 (7%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        1/13.88          1/14.62          2/14.15          1/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        7.2%             6.8%             14.1%            6.8%             0.0%                             | 
|TERMINAL (d)       |        1/13 (8%)        1/14 (7%)        2/12 (17%)       1/14 (7%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        281 (T)          281 (T)          281 (T)          281 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.335N         P=0.748N         P=0.471          P=0.748N         P=0.573N                         | 
|POLY 3             |        P=0.290N         P=0.749N         P=0.507          P=0.749N         P=0.522N                         | 
|POLY 1.5           |        P=0.277N         P=0.750N         P=0.511          P=0.750N         P=0.512N                         | 
|POLY 6             |        P=0.303N         P=0.751N         P=0.498          P=0.751N         P=0.534N                         | 
|LOGISTIC REGRESSION|        P=0.335N         P=0.748N         P=0.471          P=0.748N         (e)                              | 
|COCH-ARM / FISHERS |        P=0.256N         P=0.759N         P=0.500          P=0.759N         P=0.500N                         | 
|ORDER RESTRICTED   |        P=0.328N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 27      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Spleen                                                                                                                           | 
|     Atrophy                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          1/15.00          2/12.48                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             6.7%             16.0%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              201              217                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.023 *        (e)              (e)              P=0.514          P=0.197                          | 
|POLY 3             |        P=0.023 *        (e)              (e)              P=0.514          P=0.205                          | 
|POLY 1.5           |        P=0.026 *        (e)              (e)              P=0.509          P=0.216                          | 
|POLY 6             |        P=0.020 *        (e)              (e)              P=0.521          P=0.192                          | 
|LOGISTIC REGRESSION|        P=0.109          (e)              (e)              P=0.425          P=0.434                          | 
|COCH-ARM / FISHERS |        P=0.030 *        (e)              (e)              P=0.500          P=0.241                          | 
|ORDER RESTRICTED   |        P=0.033 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Spleen                                                                                                                           | 
|     Atrophy                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 28      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Spleen                                                                                                                           | 
|     Hematopoietic Cell Proliferation                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        4/15 (27%)       7/15 (47%)       7/15 (47%)       5/15 (33%)       5/15 (33%)                       | 
|POLY-3 RATE (b)    |        4/15.00          7/15.00          7/15.00          5/14.37          5/12.79                          | 
|POLY-3 PERCENT (g) |        26.7%            46.7%            46.7%            34.8%            39.1%                            | 
|TERMINAL (d)       |        2/13 (15%)       6/14 (43%)       5/13 (39%)       5/14 (36%)       2/7 (29%)                        | 
|FIRST INCIDENCE    |        196              253              146              280 (T)          208                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.283          P=0.295          P=0.256          P=0.538          P=0.283                          | 
|POLY 3             |        P=0.504          P=0.227          P=0.227          P=0.470          P=0.388                          | 
|POLY 1.5           |        P=0.557N         P=0.227          P=0.227          P=0.482          P=0.434                          | 
|POLY 6             |        P=0.429          P=0.227          P=0.227          P=0.459          P=0.335                          | 
|LOGISTIC REGRESSION|        P=0.291N         (e)              (e)              P=0.464          P=0.625N                         | 
|COCH-ARM / FISHERS |        P=0.466N         P=0.225          P=0.225          P=0.500          P=0.500                          | 
|ORDER RESTRICTED   |        P=0.372          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Spleen                                                                                                                           | 
|     Hematopoietic Cell Proliferation                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        9/15 (60%)       5/15 (33%)       10/15 (67%)      10/15 (67%)      10/15 (67%)                      | 
|POLY-3 RATE (b)    |        9/15.00          5/15.00          10/15.00         10/14.62         10/14.41                         | 
|POLY-3 PERCENT (g) |        60.0%            33.3%            66.7%            68.4%            69.4%                            | 
|TERMINAL (d)       |        7/13 (54%)       4/14 (29%)       7/12 (58%)       10/14 (71%)      5/9 (56%)                        | 
|FIRST INCIDENCE    |        83               239              232              281 (T)          133                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.046 *        P=0.135N         P=0.434          P=0.585          P=0.235                          | 
|POLY 3             |        P=0.134          P=0.136N         P=0.500          P=0.463          P=0.442                          | 
|POLY 1.5           |        P=0.152          P=0.136N         P=0.500          P=0.480          P=0.465                          | 
|POLY 6             |        P=0.117          P=0.136N         P=0.500          P=0.440          P=0.418                          | 
|LOGISTIC REGRESSION|        P=0.254          (e)              (e)              P=0.468          P=0.574                          | 
|COCH-ARM / FISHERS |        P=0.181          P=0.136N         P=0.500          P=0.500          P=0.500                          | 
|ORDER RESTRICTED   |        P=0.169          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 29      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach                                                                                                             | 
|     Ulcer                                                                                                                       | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        1/15 (7%)        0/15 (0%)        0/15 (0%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.95          1/15.00          0/13.80          0/14.37          3/12.19                          | 
|POLY-3 PERCENT (g) |        0.0%             6.7%             0.0%             0.0%             24.6%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        1/7 (14%)                        | 
|FIRST INCIDENCE    |        ---              253              ---              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.009 **       P=0.529          (e)              (e)              P=0.066                          | 
|POLY 3             |        P=0.017 *        P=0.514          (e)              (e)              P=0.080                          | 
|POLY 1.5           |        P=0.018 *        P=0.509          (e)              (e)              P=0.091                          | 
|POLY 6             |        P=0.017 *        P=0.521          (e)              (e)              P=0.067                          | 
|LOGISTIC REGRESSION|        P=0.054          P=0.372          (e)              (e)              P=0.155                          | 
|COCH-ARM / FISHERS |        P=0.023 *        P=0.500          (e)              (e)              P=0.112                          | 
|ORDER RESTRICTED   |        P=0.005 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach                                                                                                             | 
|     Ulcer                                                                                                                       | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          0/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 3             |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 1.5           |        (e)              (e)              (e)              (e)              (e)                              | 
|POLY 6             |        (e)              (e)              (e)              (e)              (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              (e)                              | 
|COCH-ARM / FISHERS |        (e)              (e)              (e)              (e)              (e)                              | 
|ORDER RESTRICTED   |        (e)              (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 30      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach: Epithelium                                                                                                 | 
|     Hyperplasia                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        1/15 (7%)        1/15 (7%)        0/15 (0%)        6/15 (40%)                       | 
|POLY-3 RATE (b)    |        0/13.95          1/15.00          1/14.14          0/14.37          6/13.56                          | 
|POLY-3 PERCENT (g) |        0.0%             6.7%             7.1%             0.0%             44.3%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        1/7 (14%)                        | 
|FIRST INCIDENCE    |        ---              253              244              ---              181                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       P=0.529          P=0.515          (e)              P=0.009 **                       | 
|POLY 3             |        P<0.001 **       P=0.514          P=0.503          (e)              P=0.004 **                       | 
|POLY 1.5           |        P<0.001 **       P=0.509          P=0.500          (e)              P=0.004 **                       | 
|POLY 6             |        P<0.001 **       P=0.521          P=0.508          (e)              P=0.003 **                       | 
|LOGISTIC REGRESSION|        P=0.005 **       P=0.372          P=0.538          (e)              P=0.031 *                        | 
|COCH-ARM / FISHERS |        P<0.001 **       P=0.500          P=0.500          (e)              P=0.008 **                       | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach: Epithelium                                                                                                 | 
|     Hyperplasia                                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        4/15 (27%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          1/14.62          4/13.12                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             6.8%             30.5%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        1/14 (7%)        3/9 (33%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              281 (T)          186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              P=0.515          P=0.031 *                        | 
|POLY 3             |        P<0.001 **       (e)              (e)              P=0.510          P=0.037 *                        | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              P=0.510          P=0.041 *                        | 
|POLY 6             |        P<0.001 **       (e)              (e)              P=0.509          P=0.033 *                        | 
|LOGISTIC REGRESSION|        P<0.001 **       (e)              (e)              P=0.515          P=0.055                          | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              P=0.500          P=0.050                          | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 31      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Glandular                                                                                                               | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        10/15 (67%)      0/15 (0%)        0/15 (0%)        5/15 (33%)       1/15 (7%)                        | 
|POLY-3 RATE (b)    |        10/13.95         0/14.74          0/13.80          5/14.37          1/11.42                          | 
|POLY-3 PERCENT (g) |        71.7%            0.0%             0.0%             34.8%            8.8%                             | 
|TERMINAL (d)       |        10/13 (77%)      0/14 (0%)        0/13 (0%)        5/14 (36%)       1/7 (14%)                        | 
|FIRST INCIDENCE    |        280 (T)          ---              ---              280 (T)          280 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.120N         P<0.001N**       P<0.001N**       P=0.042N*        P=0.015N*                        | 
|POLY 3             |        P=0.028N*        P<0.001N**       P<0.001N**       P=0.047N*        P<0.001N**                       | 
|POLY 1.5           |        P=0.020N*        P<0.001N**       P<0.001N**       P=0.054N         P<0.001N**                       | 
|POLY 6             |        P=0.040N*        P<0.001N**       P<0.001N**       P=0.040N*        P<0.001N**                       | 
|LOGISTIC REGRESSION|        P=0.120N         (e)              (e)              P=0.042N*        P=0.015N*                        | 
|COCH-ARM / FISHERS |        P=0.036N*        P<0.001N**       P<0.001N**       P=0.072N         P<0.001N**                       | 
|ORDER RESTRICTED   |        P<0.001N**       (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Glandular                                                                                                               | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        4/15 (27%)       0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        4/13.88          0/14.62          0/14.15          0/14.62          2/12.41                          | 
|POLY-3 PERCENT (g) |        28.8%            0.0%             0.0%             0.0%             16.1%                            | 
|TERMINAL (d)       |        4/13 (31%)       0/14 (0%)        0/12 (0%)        0/14 (0%)        2/9 (22%)                        | 
|FIRST INCIDENCE    |        281 (T)          ---              ---              ---              281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.625N         P=0.047N*        P=0.064N         P=0.047N*        P=0.517N                         | 
|POLY 3             |        P=0.496N         P=0.038N*        P=0.042N*        P=0.038N*        P=0.381N                         | 
|POLY 1.5           |        P=0.505N         P=0.039N*        P=0.041N*        P=0.039N*        P=0.354N                         | 
|POLY 6             |        P=0.483N         P=0.039N*        P=0.044N*        P=0.039N*        P=0.411N                         | 
|LOGISTIC REGRESSION|        P=0.625N         (e)              (e)              (e)              P=0.517N                         | 
|COCH-ARM / FISHERS |        P=0.500N         P=0.050N         P=0.050N         P=0.050N         P=0.326N                         | 
|ORDER RESTRICTED   |        P=0.013N*        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 32      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Glandular: Muscularis                                                                                                   | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        1/15 (7%)        0/15 (0%)                        | 
|POLY-3 RATE (b)    |        0/13.95          0/14.74          0/13.80          1/14.37          0/11.42                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             7.0%             0.0%                             | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        1/14 (7%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        ---              ---              ---              280 (T)          ---                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.580          (e)              (e)              P=0.515          (e)                              | 
|POLY 3             |        P=0.512          (e)              (e)              P=0.506          (e)                              | 
|POLY 1.5           |        P=0.570          (e)              (e)              P=0.503          (e)                              | 
|POLY 6             |        P=0.431          (e)              (e)              P=0.509          (e)                              | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              P=0.515          (e)                              | 
|COCH-ARM / FISHERS |        P=0.639          (e)              (e)              P=0.500          (e)                              | 
|ORDER RESTRICTED   |        P=0.387          (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Glandular: Muscularis                                                                                                   | 
|     Mineralization                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        0/15 (0%)        0/15 (0%)        0/15 (0%)        2/15 (13%)                       | 
|POLY-3 RATE (b)    |        0/13.88          0/14.62          0/14.15          0/14.62          2/12.41                          | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             16.1%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/12 (0%)        0/14 (0%)        2/9 (22%)                        | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              281 (T)                          | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.009 **       (e)              (e)              (e)              P=0.157                          | 
|POLY 3             |        P=0.017 *        (e)              (e)              (e)              P=0.205                          | 
|POLY 1.5           |        P=0.017 *        (e)              (e)              (e)              P=0.217                          | 
|POLY 6             |        P=0.016 *        (e)              (e)              (e)              P=0.193                          | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              P=0.157                          | 
|COCH-ARM / FISHERS |        P=0.021 *        (e)              (e)              (e)              P=0.241                          | 
|ORDER RESTRICTED   |        P=0.010 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 33      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Thymus                                                                                                                           | 
|     Atrophy                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/15 (13%)       0/15 (0%)        1/15 (7%)        0/15 (0%)        4/15 (27%)                       | 
|POLY-3 RATE (b)    |        2/15.00          0/14.74          1/14.66          0/14.37          4/12.77                          | 
|POLY-3 PERCENT (g) |        13.3%            0.0%             6.8%             0.0%             31.3%                            | 
|TERMINAL (d)       |        0/13 (0%)        0/14 (0%)        0/13 (0%)        0/14 (0%)        0/7 (0%)                         | 
|FIRST INCIDENCE    |        196              ---              146              ---              210                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.039 *        P=0.232N         P=0.508N         P=0.240N         P=0.231                          | 
|POLY 3             |        P=0.048 *        P=0.236N         P=0.508N         P=0.241N         P=0.249                          | 
|POLY 1.5           |        P=0.051          P=0.234N         P=0.504N         P=0.238N         P=0.280                          | 
|POLY 6             |        P=0.046 *        P=0.239N         P=0.514N         P=0.245N         P=0.217                          | 
|LOGISTIC REGRESSION|        P=0.367          (e)              (e)              P=0.207N         P=0.662                          | 
|COCH-ARM / FISHERS |        P=0.061          P=0.241N         P=0.500N         P=0.241N         P=0.326                          | 
|ORDER RESTRICTED   |        P=0.013 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Thymus                                                                                                                           | 
|     Atrophy                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/15 (0%)        2/15 (13%)       0/15 (0%)        1/15 (7%)        3/15 (20%)                       | 
|POLY-3 RATE (b)    |        0/13.88          2/15.00          0/14.15          1/14.62          3/14.05                          | 
|POLY-3 PERCENT (g) |        0.0%             13.3%            0.0%             6.8%             21.4%                            | 
|TERMINAL (d)       |        0/13 (0%)        1/14 (7%)        0/12 (0%)        1/14 (7%)        0/9 (0%)                         | 
|FIRST INCIDENCE    |        ---              239              ---              281 (T)          186                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.047 *        P=0.256          (e)              P=0.515          P=0.111                          | 
|POLY 3             |        P=0.066          P=0.250          (e)              P=0.510          P=0.107                          | 
|POLY 1.5           |        P=0.066          P=0.246          (e)              P=0.510          P=0.108                          | 
|POLY 6             |        P=0.067          P=0.252          (e)              P=0.509          P=0.107                          | 
|LOGISTIC REGRESSION|        P=0.105          P=0.197          (e)              P=0.515          P=0.108                          | 
|COCH-ARM / FISHERS |        P=0.066          P=0.241          (e)              P=0.500          P=0.112                          | 
|ORDER RESTRICTED   |        P=0.028 *        (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  04/14/04                           EXPERIMENT: 99035 TEST: 01                                            Page 34      
Statistical Analysis of Non-neoplastic Lesions in       Mice(P16(INK4A)/(+/-) (C57BL/6))  -         TRANSGENIC MODEL EVALUATION II (
GLY                                                                                                                                 
                                         Terminal Sacrifice at 40 weeks                                                             
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Males                                                  | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Uterus: Endometrium                                                                                                              | 
|     Hyperplasia Cystic                                                                                                          | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |                                                                                                             | 
|POLY-3 RATE (b)    |                                                                                                             | 
|POLY-3 PERCENT (g) |                                                                                                             | 
|TERMINAL (d)       |                                                                                                             | 
|FIRST INCIDENCE    |                                                                                                             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |                                                                                                             | 
|POLY 3             |                                                                                                             | 
|POLY 1.5           |                                                                                                             | 
|POLY 6             |                                                                                                             | 
|LOGISTIC REGRESSION|                                                                                                             | 
|COCH-ARM / FISHERS |                                                                                                             | 
|ORDER RESTRICTED   |                                                                                                             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 MG/KG          25 MG/KG         50 MG/KG         100              200                              | 
|                   |                                                           MG/KG            MG/KG                            | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Uterus: Endometrium                                                                                                              | 
|     Hyperplasia Cystic                                                                                                          | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|LESION RATES       |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        13/15 (87%)      14/15 (93%)      10/15 (67%)      14/15 (93%)      9/15 (60%)                       | 
|POLY-3 RATE (b)    |        13/13.88         14/14.62         10/14.15         14/15.00         9/12.44                          | 
|POLY-3 PERCENT (g) |        93.6%            95.8%            70.7%            93.3%            72.3%                            | 
|TERMINAL (d)       |        13/13 (100%)     14/14 (100%)     10/12 (83%)      13/14 (93%)      8/9 (89%)                        | 
|FIRST INCIDENCE    |        281 (T)          281 (T)          281 (T)          239              278                              | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.561          P=1.000          P=0.217N         P=0.760          P=0.740N                         | 
|POLY 3             |        P=0.109N         P=0.741          P=0.121N         P=0.765N         P=0.146N                         | 
|POLY 1.5           |        P=0.072N         P=0.702          P=0.121N         P=0.731          P=0.102N                         | 
|POLY 6             |        P=0.155N         P=0.767          P=0.138N         P=0.742N         P=0.221N                         | 
|LOGISTIC REGRESSION|        P=0.259N         P=1.000          P=0.217N         P=0.716          (e)                              | 
|COCH-ARM / FISHERS |        P=0.051N         P=0.500          P=0.195N         P=0.500          P=0.107N                         | 
|ORDER RESTRICTED   |        P=0.060N         (e)              (e)              (e)              (e)                              | 
|=================================================================================================================================| 
(a)  Number of tumor-bearing animals /  number of animals examined at site.                                                         
                                                                                                                                   
(b)  Number of tumor-bearing animals / Poly-3 number                                                                                
(d)  Observed incidence at terminal kill.                                                                                           
(f)  Beneath the control incidence are the P-values associated with the trend                                                       
test.  Beneath the dosed group incidence are the P-values corresponding to                                                          
pairwise comparisons between the controls and that dosed group.  The life                                                           
table analysis regards tumors in animals dying prior to  terminal kill as                                                           
 being (directly or indirectly) the cause of death.                                                                                 
Logistic regression is an alternative                                                                                               
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage                                                       
and Fishers exact tests compare directly the overall incidence rates                                                                
For all tests a negative trend is indicated by N                                                                                    
(e)  Value of Statistic cannot be computed.                                                                                         
(g)  Poly-3 adjusted lifetime tumor incidence.                                                                                      
(I)  Interim sacrifice                                                                                                              
(T)  Terminal sacrifice                                                                                                             
#   Tumor rates based on number of animals necropsied.                                                                              
*   To the right of any statistical result, indicates significance at (P<=0.05).                                                    
**  To the right of any statistical result, indicates significance at (P<=0.01).